The Traderszone Network

Published in TZ Latest News 31 October, 2017 by The TZ Newswire Staff

Dr. Frédéric Triebel Presented at the World Immunotherapy Congress 2017

SYDNEY, Australia, Oct. 31, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) announces that Dr. Frédéric Triebel, Prima’s Chief Scientific Officer and Medical Officer, gave an oral presentation at the World Immunotherapy Congress 2017 in Basel, Switzerland at 5.50pm CEST on October 31, 2017.